Inventor

KLEBL BERT

DE8 patents

⚠️ This page may combine multiple inventors who share the name “KLEBL BERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEAD DISCOVERY CENTER GMBH

2 patents

US11111238B2Sep 7, 2021

Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

LEAD DISCOVERY CENTER GMBH0 citations41

US10703735B2Jul 7, 2020

4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

LEAD DISCOVERY CENTER GMBH0 citations31

CHOIDAS AXEL

1 patent

US8084457B2Dec 27, 2011

Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases

CHOIDAS AXEL76 citations89

SCHULTZ-FADEMRECHT CARSTEN

1 patent

US8999982B2Apr 7, 2015

Pharmaceutically active compounds as Axl inhibitors

SCHULTZ-FADEMRECHT CARSTEN10 citations78

RÜHTER GERD

1 patent

US9242937B2Jan 26, 2016

Pharmaceutically active disubstituted pyridine derivatives

RÜHTER GERD5 citations67

WABNITZ PHILIPP

1 patent

US8507498B2Aug 13, 2013

4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases

WABNITZ PHILIPP4 citations55

GPC BIOTECH AG

1 patent

US7341717B2Mar 11, 2008

Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor

GPC BIOTECH AG1 citations44

SANOFI AVENTIS DEUTSCHLAND

1 patent

US7319024B1Jan 15, 2008

C. elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of PAK activity in the nematode, caenorhabditis elegans

SANOFI AVENTIS DEUTSCHLAND0 citations39